Gossamer Bio
(NASDAQ:GOSS)
$0.8003
-0.0205[-2.50%]
At close: Apr 17
$0.8003
0[0.00%]
After Hours: 4:32PM EDT
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Gossamer Bio Stock (NASDAQ:GOSS), Quotes and News Summary

Gossamer Bio Stock (NASDAQ: GOSS) stock price, news, charts, stock research, profile.

Open$0.829
Close$0.820
Volume / Avg.936.597K / 1.284M
Day Range0.800 - 0.856
52 Wk Range0.453 - 1.880
Market Cap$180.533M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
26
Short Interest
5.61%
Days to Cover8.46

Recent News

Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) fell sharply during Monday’s session after the company and POINT Biopharma announced topline results from the pivotal phase 3 SPLASH study in metastatic castration-resistant prostate cancer.
Avi Kapoor
Gossamer Bio And 2 Other Stocks Under $1 Insiders Are Buying
The Dow Jones closed higher by around 490 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Lisa Levin
Why MIND Technology Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers WeTrade Group, Inc. (NASDAQ: WETG) shares climbed 140.3% to $20.28. WeTrade launched large-scale language processing models to increase product applications in the field of artificial intelligence.
Lisa Levin
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Nov 23
1
Dec 23
1
Jan
4
Mar
1
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
3.5
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
About Gossamer Bio Inc
Sector
Health Care
Industry
Biotechnology
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
GOSS
SYRS

FAQ

Q

How do I buy Gossamer Bio (GOSS) stock?

A

You can purchase shares of Gossamer Bio (NASDAQ: GOSS) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Gossamer Bio's (GOSS) competitors?

A

Other companies in Gossamer Bio’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Outlook Therapeutics (NASDAQ:OTLK), bluebird bio (NASDAQ:BLUE), Atossa Therapeutics (NASDAQ:ATOS) and NuCana (NASDAQ:NCNA).

Q

What is the target price for Gossamer Bio (GOSS) stock?

A

The latest price target for Gossamer Bio (NASDAQ: GOSS) was reported by Wedbush on Friday, April 5, 2024. The analyst firm set a price target for 4.00 expecting GOSS to rise to within 12 months (a possible 399.81% upside). 14 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Gossamer Bio (GOSS)?

A

The stock price for Gossamer Bio (NASDAQ: GOSS) is $0.8003 last updated April 17, 2024 at 4:32 PM EDT.

Q

Does Gossamer Bio (GOSS) pay a dividend?

A

There are no upcoming dividends for Gossamer Bio.

Q

When is Gossamer Bio (NASDAQ:GOSS) reporting earnings?

A

Gossamer Bio’s Q1 earnings are confirmed for Tuesday, May 7, 2024.

Q

Is Gossamer Bio (GOSS) going to split?

A

There is no upcoming split for Gossamer Bio.

Q

What sector and industry does Gossamer Bio (GOSS) operate in?

A

Gossamer Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch